secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0001193125-24-269949
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences hosts R&D Day focusing on FB102 autoimmune updates
--------------------------------------------------------------------

- R&D Day held December 3, 2024 highlighting FB102 development in autoimmune indications.
- Slide deck (Ex-99.1) and updated corporate presentation (Ex-99.2) furnished with the filing.
- No specific clinical data or financial guidance disclosed in the 8-K or exhibits.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312524269949/0001193125-24-269949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312524269949/d850569d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-269949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer